Logos Global Management LP Q3 2023 Filing
Filed November 14, 2023
Portfolio Value
$749.5T
Holdings
53
Report Date
Q3 2023
Filing Type
13F-HR
All Holdings (53 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IMVTIMMUNOVANT INC | 1,600,000 | $61.4T | 8.19% | |
| 2 | IDYAIDEAYA BIOSCIENCES INC | 2,250,000 | $60.7T | 8.10% | |
| 3 | APLSAPELLIS PHARMACEUTICALS INC | 1,400,000 | $53.3T | 7.11% | Call |
| 4 | OLMAOLEMA PHARMACEUTICALS INC | 3,743,875 | $46.2T | 6.17% | |
| 5 | RCKTROCKET PHARMACEUTICALS INC | 1,975,000 | $40.5T | 5.40% | |
| 6 | CYTKCYTOKINETICS INC | 1,250,000 | $36.8T | 4.91% | |
| 7 | AKROAKERO THERAPEUTICS INC | 600,000 | $30.3T | 4.05% | |
| 8 | GPCRSTRUCTURE THERAPEUTICS INC | 500,000 | $25.2T | 3.36% | |
| 9 | SRPTSAREPTA THERAPEUTICS INC | 200,000 | $24.2T | 3.23% | |
| 10 | BBIOBRIDGEBIO PHARMA INC | 900,000 | $23.7T | 3.17% | Call |
| 11 | IMCRIMMUNOCORE HLDGS PLC | 450,000 | $23.4T | 3.12% | |
| 12 | —ICOSAVAX INC | 2,765,741 | $21.4T | 2.86% | |
| 13 | DYNDYNE THERAPEUTICS INC | 2,180,000 | $19.5T | 2.61% | |
| 14 | KRTXKARUNA THERAPEUTICS INC | 115,000 | $19.4T | 2.59% | |
| 15 | NBIXNEUROCRINE BIOSCIENCES INC | 150,000 | $16.9T | 2.25% | |
| 16 | VRDNVIRIDIAN THERAPEUTICS INC | 1,050,000 | $16.1T | 2.15% | |
| 17 | XENEXENON PHARMACEUTICALS INC | 450,000 | $15.4T | 2.05% | |
| 18 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 700,000 | $15.3T | 2.04% | |
| 19 | ROIVROIVANT SCIENCES LTD | 1,200,000 | $14.0T | 1.87% | |
| 20 | MRTXEURMIRATI THERAPEUTICS INC | 300,000 | $13.1T | 1.74% | |
| 21 | ANNXANNEXON INC | 5,300,000 | $12.5T | 1.67% | |
| 22 | IMTXIMMATICS N.V | 1,050,000 | $12.2T | 1.62% | |
| 23 | DSGNDESIGN THERAPEUTICS INC | 5,032,501 | $11.9T | 1.58% | |
| 24 | ALLKGUSDALLAKOS INC | 4,650,000 | $10.6T | 1.41% | |
| 25 | RPTXREPARE THERAPEUTICS INC | 800,000 | $9.7T | 1.29% | Call |
| 26 | RYTMRHYTHM PHARMACEUTICALS INC | 400,000 | $9.2T | 1.22% | |
| 27 | KALVKALVISTA PHARMACEUTICALS INC | 900,000 | $8.7T | 1.16% | |
| 28 | VTYXVENTYX BIOSCIENCES INC | 225,000 | $7.8T | 1.04% | |
| 29 | CRNXCRINETICS PHARMACEUTICALS IN | 250,000 | $7.4T | 0.99% | |
| 30 | GRCLGRACELL BIOTECHNOLOGIES INC | 2,525,000 | $7.3T | 0.97% | |
| 31 | CMPSCOMPASS PATHWAYS PLC | 950,000 | $7.0T | 0.94% | |
| 32 | RVMDREVOLUTION MEDICINES INC | 250,000 | $6.9T | 0.92% | |
| 33 | MOR2MORPHOSYS AG | 950,000 | $6.4T | 0.85% | |
| 34 | GONGERON CORP | 2,750,000 | $5.8T | 0.78% | |
| 35 | MRUSMERUS N V | 245,000 | $5.8T | 0.77% | |
| 36 | ALXOALX ONCOLOGY HLDGS INC | 1,000,000 | $4.8T | 0.64% | |
| 37 | ETNBGBP89BIO INC | 310,000 | $4.8T | 0.64% | |
| 38 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1,000,000 | $4.5T | 0.61% | Call |
| 39 | DCTHDELCATH SYS INC | 1,044,444 | $4.2T | 0.56% | |
| 40 | ELVNENLIVEN THERAPEUTICS INC | 307,076 | $4.2T | 0.56% | |
| 41 | CATBUSDASTRIA THERAPEUTICS INC | 544,960 | $4.1T | 0.54% | |
| 42 | SLNOSOLENO THERAPEUTICS INC | 125,000 | $3.7T | 0.49% | |
| 43 | VERVVERVE THERAPEUTICS INC | 215,000 | $2.9T | 0.38% | |
| 44 | ZURAZURA BIO LTD | 424,000 | $2.8T | 0.37% | |
| 45 | SYREAEGLEA BIOTHERAPEUTICS INC | 210,000 | $2.6T | 0.34% | |
| 46 | —AMBRX BIOPHARMA INC | 115,000 | $1.3T | 0.18% | |
| 47 | VIGLVIGIL NEUROSCIENCE INC | 188,390 | $1.0T | 0.14% | |
| 48 | IOBTIO BIOTECH INC | 493,827 | $696.3B | 0.09% | |
| 49 | IMUXIMMUNIC INC | 421,184 | $619.1B | 0.08% | |
| 50 | CYPHLEAP THERAPEUTICS INC | 354,266 | $488.9B | 0.07% | |
| 51 | TYRATYRA BIOSCIENCES INC | 31,872 | $438.9B | 0.06% | |
| 52 | LIANYLIANBIO | 280,000 | $417.2B | 0.06% | |
| 53 | NUVB/WSNUVATION BIO INC | 66,666 | $6.7B | 0.00% |